Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

We've Got Mail #53 | Which Classic Movies Are Eerily Relevant Today?

We've Got Mail #53 | Which Classic Movies Are Eerily Relevant Today?

FromCritically Acclaimed Network


We've Got Mail #53 | Which Classic Movies Are Eerily Relevant Today?

FromCritically Acclaimed Network

ratings:
Length:
74 minutes
Released:
Nov 3, 2020
Format:
Podcast episode

Description

It's an all-new episode of WE'VE GOT MAIL, the podcast where film critics William Bibbiani and Witney Seibold answer YOUR letters! This week, Bibbs and Witney ponder what America really means on Election Day, and also get more into generational divides, what makes a great movie franchise, which serial killers would be least likely to kill them, and which classic movies feel eerily prescient about our current circumstances? Email us at letters@criticallyacclaimed.net, so we can read your correspondence and answer YOUR questions in future episodes! Subscribe on Patreon at www.patreon.com/criticallyacclaimednetwork for exclusive content and exciting rewards, like bonus episodes, commentary tracks and much, much more! And visit our TeePublic page to buy shirts, mugs and other exciting merchandise!  Follow us on Twitter at @CriticAcclaim, join the official Fan Club on Facebook, follow Bibbs at @WilliamBibbiani and follow Witney at @WitneySeibold, and head on over to www.criticallyacclaimed.net for all their podcasts, reviews and more! Support the show: https://www.patreon.com//criticallyacclaimednetworkAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
Released:
Nov 3, 2020
Format:
Podcast episode

Titles in the series (100)

Film critics William Bibbiani and Witney Seibold host a series of ongoing shows, featuring CRITICALLY ACCLAIMED (new movie reviews), CANCELED TOO SOON (retrospectives of short-lived TV shows), WE'VE GOT MAIL, CRITICALLY RECLAIMED, THE IRON LIST, and more!